CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2015; 25(02): 162-166
DOI: 10.4103/0971-3026.155866
Neuroradiology

Role of dynamic CT perfusion study in evaluating various intracranial space-occupying lesions

Ravindra B Kamble
Department of Radiology, Vikram Hospital, Bangalore, Karnataka, India
,
Peruvumba N Jayakumar
Department of Radiology, Khoula Hospital, Muscat, United States
,
Ravishankar Shivashankar
Department of Radiology, University of Maryland Medical Center, Baltimore, Maryland, United States
› Author Affiliations

Abstract

Aims: Differentiating intracranial mass lesions on CT scan is challenging. The purpose of our study was to determine the perfusion parameters in various intracranial space-occupying lesions (ICSOL), differentiate benign and malignant lesions, and differentiate between grades of gliomas. Materials and Methods: We performed CT perfusion (CTP) in 64 patients, with age ranging from 17 to 68 years, having space-occupying lesions in brain and calculated relative cerebral blood flow (rCBF) and relative cerebral blood volume (rCBV). Results: We found significantly lower perfusion in low-grade gliomas as compared to high-grade tumors, lymphoma, and metastases. Similarly in infective lesions, TWT and abscesses showed significantly lower perfusion compared to TOT. In ring enhancing lesions, capsule of TWT showed significantly lower perfusion as compared to abscesses, TOT, and metastases. Conclusion: Thus, in conclusion, infective lesions can be differentiated from tumors like lymphomas, high-grade gliomas, or metastases based on perfusion parameters. The cut off value of rCBV 1.64 can be used to differentiate between low grade and high grade gliomas. However, depending only on perfusion parameters, differentiation between the tumors like lymphomas, high-grade gliomas, and metastases may not be possible.



Publication History

Article published online:
30 July 2021

© 2015. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 Floriano VH, Ferraz-Filho JR, Spotti AR, Tognola WA. Perfusion-weighted magnetic resonance imaging in the evaluation of focal neoplastic and infectious brain lesions. Rev Bras Neurol 2010;46:29-36.
  • 2 Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, et al. Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings. Radiology 1994;191:41-51.
  • 3 Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T, et al. Posttherapeutic intraaxial brain tumor: The value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000;21:901-9.
  • 4 Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR Am J Neuroradiol 1995;16:1593-603.
  • 5 Möller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002;44:371-81.
  • 6 Roberts HC, Roberts TP, Lee TY, Dillon WP. Dynamic, contrast-enhanced ct of human brain tumors: Quantitative assessment of blood volume, blood flow, and microvascular permeability: Report of two cases. AJNR Am J Neuroradiol 2002;23:828-32.
  • 7 Eastwood JD, Provenzale JM. Cerebral blood flow, blood volume, and vascular permeability of cerebral glioma assessed with dynamic CT perfusion imaging. Neuroradiology 2003;45:373-6.
  • 8 Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. Dynamic CT measurement of cerebral blood flow: A validation study. AJNR Am J Neuroradiol 1999;20:63-73.
  • 9 Russel D, Rubinstein L. Tumors of central neuroepithelial origin. In: Rubenstein LJ, editor. Pathology of Tumors of Nervous System. Baltimore, Maryland: Williams and Wilkins; 1989. p. 83-350.
  • 10 Wintermark M, Thiran JP, Maeder P, Schnyder P, Meuli R. Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: A validation study. AJNR Am J Neuroradiol 2001;22:905-14.
  • 11 Wintermark M, Reichhart M, Cuisenaire O, Maeder P, Thiran JP, Schnyder P, et al. Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke 2002;33:2025-31.
  • 12 Holmes TM, Petrella JR, Provenzale JM. Distinction between cerebral abscesses and high-grade neoplasms by dynamic susceptibility contrast perfusion MRI. AJR Am J Roentgenol 2004;183:1247-52.
  • 13 Batra A, Tripathi RP. Perfusion magnetic resonance imaging in intracerebral parenchymal tuberculosis: Preliminary findings. J Comput Assist Tomogr 2003;27:882-8.
  • 14 Ernst TM, Chang L, Witt MD, Aronow HA, Cornford ME, Walot I, et al. Cerebral toxoplasmosis and lymphoma in AIDS: Perfusion MR imaging experience in 13 patients. Radiology 1998;208:663-9.
  • 15 Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: Dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11-29.
  • 16 Sugahara M, Korogi K, Kochi M, Ikushima I, Hirai T, Okuda T, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171:1479-86.
  • 17 Cho SK, Na DG, Ryoo JW, Roh HG, Moon CH, Byun HS, et al. Perfusion MR imaging: Clinical utility for the differential diagnosis of various brain tumors. Korean J Radiol 2002;3:171-9.
  • 18 Sankhe S, Baheti A, Ihare A, Mathur S, Dabhade P, Sarode A. Perfusion magnetic resonance imaging characteristics of intracerebral tuberculomas and its role in differentiating tuberculomas from metastases. Acta Radiol 2013;54:307-12.
  • 19 Law Y, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW. High grade gliomas and solitary metastases: Differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002;222:715-21.
  • 20 Jinkins JR, Al-Kawi MZ, Bashir R. Dynamic computed tomography of cerebral parenchymal tuberculomata. Neuroradiology 1987;29:523-9.
  • 21 Dastur DK, Dave UP. Ultrastructural Basis of the Vasculopathy In and Around Brain Tuberculomas. Possible significance of altered basement membrane. Am J Pathol 1977;89:35-50.